Home›Stock Screener›Mahamaya Lifesciences

Mahamaya Lifesciences Share Price Today | Stock Price & Mahamaya Lifesciences Share Screener

MAHALIFE Pesticides & Agrochemicals

Track the current Mahamaya Lifesciences share price and stock price live with TickJournal's free stock screener. Check MAHALIFE 52-week high low for the annual price range and momentum. Use the Mahamaya Lifesciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Mahamaya Lifesciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹118 and net income of ₹5, with EBITDA of ₹10, an operating margin of 8.0% and a profit margin of 4.2%.

Mahamaya Lifesciences Market Cap ₹423.01 Cr.
MAHALIFE P/E Ratio (TTM) 25.64
Mahamaya Lifesciences P/B Ratio 3.47
EPS (TTM) ₹8.33
Dividend Yield -
Debt to Equity 1.52
MAHALIFE 52 Week High -
Mahamaya Lifesciences 52 Week Low -
Operating Margin 8.00%
Profit Margin 4.24%
MAHALIFE Revenue (TTM) ₹118.00
EBITDA ₹10.00
Net Income ₹5.00
Total Assets ₹310.00
Total Equity ₹122.00

Mahamaya Lifesciences Share Price Chart

Track the current stock price of Mahamaya Lifesciences with an interactive chart. Analyse MAHALIFE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Mahamaya Lifesciences stock quote in one place.

Mahamaya Lifesciences Company Profile - Fundamental Screener

Screen Mahamaya Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MAHALIFE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Chemicals sector and the Pesticides & Agrochemicals industry, and it trades under ISIN INE0U9D01019.

Company Details

Classification

Sector Chemicals
Industry Pesticides & Agrochemicals
Sub-Sector Pesticides & Agrochemicals
Segment E

Identifiers and Leadership

ISIN INE0U9D01019

Mahamaya Lifesciences Balance Sheet Screener

Screen MAHALIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹310, up from ₹188 in 2025.

Latest statistics put total assets at ₹310 and shareholder funds at ₹122, with a leverage ratio of 1.52.

Item 2026 2025 2024 2023 2022

Assets

Total Assets 310 188 112 78 56
Current Assets 267 157 87 54 33
Fixed Assets 43 27 22 21 20

Liabilities

Total Liabilities 0 0 0 0 0
Current Liabilities 5 7 9 11 10
Non-Current Liabilities 0 0 0 0 0

Shareholders' Equity

Total Equity 122 49 25 19 16
Share Capital 23 18 1 1 1
Reserves & Surplus 99 32 23 18 15

Mahamaya Lifesciences Income Statement Screener - Profit & Revenue Analysis

Screen Mahamaya Lifesciences income statement and profit fundamentals. Analyze MAHALIFE quarterly results. Mahamaya Lifesciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2025-Mar, revenue was ₹118 and net profit was ₹5, equal to earnings per unit of ₹3.04, at an operating margin of 8%.

In that period expenses were ₹109, interest cost ₹3 and tax ₹2. The next period listed, 2024-Dec, shows revenue of ₹0 and net profit of ₹0.

Item 2025-Mar 2024-Dec

Revenue and Expenses

Revenue 118 0
Expenses 109 0

Operating Costs and Margins

EBITDA 10 0
Operating Profit % 8.00% 0.00%
Depreciation 1 0
Interest 3 0

Profit and Earnings

Profit Before Tax 7 0
Tax 2 0
Net Profit 5 0
EPS 3.04 0.00

Mahamaya Lifesciences Cash Flow Screener - Liquidity Fundamentals

Screen MAHALIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹1, and net cash flow was an inflow of ₹1.

Over the same period, investing activities used ₹8 and financing activities provided ₹9.

Item 2025-March 2024-March 2023-March 2022-March

Cash from Operations and Investing

Operating Activities 1 -23 1 2
Investing Activities -8 -2 -3 -3

Financing and Net Cash

Financing Activities 9 24 2 1
Net Cash Flow 1 0 1 0

Mahamaya Lifesciences Shareholding Pattern Screener

See Mahamaya Lifesciences shareholding pattern with promoter, FII, and DII holdings. Check Mahamaya Lifesciences promoter holding and ownership changes for MAHALIFE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 56.35%, foreign institutions 4.77%, domestic institutions 2.52% and the public 10.65%, spread across 584 shareholders.

The shareholder count was 584 in 2026-Mar, compared with 18 in 2025-Feb.

Item 2026-Mar 2025-Feb 2025-Oct 2025-Nov

Promoter Holding

Promoter Holding 56.35% 77.27% 77.27% 56.35%

Institutional Investors

FII Holding 4.77% 0.00% 0.00% 6.39%
DII Holding 2.52% 0.00% 0.00% 4.67%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00%
Public Holding 10.65% 0.00% 0.00% 12.72%
Other Holding 25.71% 22.73% 22.73% 19.88%
Shareholder Count 584 18 18 1,034

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Mahamaya Lifesciences. Mahamaya Lifesciences dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Mahamaya Lifesciences.

Mahamaya Lifesciences Stock Index Membership - Nifty & Sensex

See which indices include Mahamaya Lifesciences stock. Check MAHALIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Mahamaya Lifesciences is not part of any tracked indices.
Only major market indices are tracked in our system.

Mahamaya Lifesciences Market Events Screener - Corporate Actions

Get Mahamaya Lifesciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Mahamaya Lifesciences stock events that may affect MAHALIFE share price, along with derivatives, futures and options activity and sector gainers.

3 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.

It is followed by Quarterly Result Announcement dated May 25, 2026 and Quarterly Result Announcement dated December 2, 2025.

Announcement Date Record Date Event Type Information Price Impact
2026-09-29 2026-09-29 Annual General Meeting NA -11.14%
2026-05-25 2026-05-25 Quarterly Result Announcement NA -1.16%
2025-12-02 2025-12-02 Quarterly Result Announcement NA -0.69%

Mahamaya Lifesciences Competitors Screener - Peer Stocks Comparison

Screen MAHALIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
UPL 45,357 19.54 52,502 11.41% 2,220 35.35
PI Industries 34,869 29.95 7,024 -15.59% 1,321 37.99
Sumitomo Chemical 22,035 37.15 3,385 3.56% 543 24.89
Bayer Crop Science 16,425 22.12 5,770 3.16% 689 13.50
Sharda Cropchem 6,544 10.39 5,410 23.53% 681 33.33
Dhanuka Agritech 4,150 13.92 2,071 15.49% 297 33.36
Rallis 3,873 31.33 2,631 6.54% 164 32.48
NACL Industries 3,148 249.62 1,587 27.74% 5 19.81
Bhagiradha Chemicals & Industries 3,119 112.38 538 19.68% 18 29.92
GSP Crop Science 2,219 22.16 1,531 17.66% 95 30.71

Mahamaya Lifesciences Company Announcements - News & Reports Screener

Screen MAHALIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated October 4, 2026 and September 8, 2026.

Date Update Actions
Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-10-04 Closure of Trading Window -
2026-09-08 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-07 Reg. 34 (1) Annual Report. -
2026-09-07 Notice Of 24Th Annual General Meeting Of The Company -
2026-09-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-25 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-08-25 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-25 Appointment of Company Secretary and Compliance Officer -
2026-08-07 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-08-04 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-07-30 Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer -
2026-07-10 Non-Applicability Of The Compliance On Corporate Governance -
2026-07-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-05-26 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-05-25 The Audited (Standalone & Consolidated) Financial Results Of The Company For The Half Year And Financial Year Ended 31.03.2026 Along With The Audit Reports Thereon -
2026-05-25 Board Meeting Outcome for Audited Financial Results (Standalone & Consolidated) For The Half Year And Year Ended On 31.03.2026 -
2026-05-20 Board Meeting Intimation for Prior Intimation Of The Board Meeting Pursuant To Regulation 29(1) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 -
2026-05-15 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-05-05 Compliances-Reg.24(A)-Annual Secretarial Compliance -

Frequently Asked Questions

How is the company valued right now?

The P/E ratio is 25.64 and the P/B ratio is 3.47, with earnings per unit of ₹8.33. Market capitalisation stands at ₹423.01 Cr. The company operates in the Chemicals sector, in the Pesticides & Agrochemicals industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on October 5, 2026. This page covers 5 balance sheet periods, 2 income statement periods, 4 cash flow years and 4 shareholding periods. Information is provided for research and is not investment advice.